NCT01935934 2025-10-01Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerNational Cancer Institute (NCI)Phase 2 Completed102 enrolled 14 charts
NCT03824704 2023-06-12A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)pharmaand GmbHPhase 2 Terminated1 enrolled 7 charts